Clinical Trials Directory

Trials / Completed

CompletedNCT02590887

Safety and Efficacy of a Drink Containing Lupine Protein Hydrolysates on the Immune, Oxidative and Metabolic Status

Clinical Study to Assess the Immunomodulatory and Antioxidant Effects of a Beverage Manufactured From Lupine Protein Hydrolysates in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
University of Seville · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the health effects of the 4 weeks daily intake of a drink manufactured from lupine protein hydrolysates in healthy volunteers. For that, blood markers of inflammation, oxidative stress, carbohydrate, lipid, protein and liver metabolism, together with general hematology and blood coagulation will be assessed at baseline time (day 0) and after drink ingestion (day +14 and +28).

Detailed description

The main objective of the present study is to verify the hypothesis that the intake of the drink based on lupine peptides is safe and has beneficial effects on the immune and oxidative status. The secondary objectives are: * Assess the effect of the drink on biological parameters of the carbohydrate, lipid, renal and hepatic metabolism as well as hematology analysis. * Assess whether the new product is well tolerated. * Evaluate the effect of the drink on the general health of the volunteers through the Short Form-36 health survey. * Determine the degree of drink acceptability through the acceptability Likert test.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDrink manufactured from lupine peptidesComparison of blood levels of immune, oxidative stress, biochemical markers and haemogram before and after (14, and 28 days) drinking the beverage.

Timeline

Start date
2015-10-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-10-29
Last updated
2020-10-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02590887. Inclusion in this directory is not an endorsement.